Tagged: finland
4 results
Haltian
Haltian is a Finnish IoT company from Oulu that turns physical spaces into smart, sustainable environments. Founded in 2012 by former Nokia product engineers, it pairs its Thingsee wireless sensor hardware with the Empathic Building digital twin software to help offices, hospitals, warehouses and logistics sites measure occupancy, air quality and asset location - and act on the data. Having earned early fame designing the Oura smart ring, Haltian now runs one of Europe's largest IoT deployments and serves roughly 400 customers across 36 countries.
ŌURA
ŌURA makes the Oura Ring, a titanium smart ring that reads sleep, recovery, heart rate, temperature and activity from the finger. Founded in Oulu, Finland in 2013 and now co-headquartered in San Francisco, it has shipped more than 5.5 million rings, surpassed $500M in 2024 revenue and reached an $11B valuation in its 2025 Series E.
Timo Korpela
Timo Korpela is CEO of Haltian Inc. and VP of Sales for North America at Haltian, the Finnish IoT pioneer behind the Thingsee sensor platform and the 'Empathic Building' concept. Raised under the Northern Lights in Finnish Lapland and educated at Helsinki University of Technology, he bridges the precision of Nordic engineering with the deal-making culture of Silicon Valley. Operating from Palo Alto, he drives Haltian's North American growth - a market that accounts for roughly a third of the company's revenue - while negotiating global partnerships with Cisco, Microsoft, and healthcare systems across three continents.
Tero-Pekka Alastalo
Tero-Pekka Alastalo is a Finnish-born physician-scientist turned serial entrepreneur who trained as a pediatric cardiologist, completed his postdoctoral work at Stanford University School of Medicine, and has spent the last 15 years building life science companies in Silicon Valley. He co-founded Blueprint Genetics in 2012 - a clinical genetic testing company later acquired by Quest Diagnostics in 2020 - before launching Avenue Biosciences in 2023, a transatlantic AI-powered protein engineering company that uses signal peptide libraries and machine learning to unlock the secretory pathway and dramatically boost therapeutic protein yields. Based in Menlo Park, California, Alastalo is turning a fundamental cellular mechanism overlooked by the industry into a platform that could accelerate every class of next-generation biologic.